| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |